Literature DB >> 28042086

Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity.

Ramin Rezaee1, Amir Abbas Momtazi2, Alireza Monemi3, Amirhossein Sahebkar4.   

Abstract

Curcumin is a naturally occurring polyphenol isolated from Curcuma longa that has gained considerable interest over the last decades due to its beneficial effects for human health. Moreover, the usage of cisplatin, a platinum-based chemotherapeutic, is associated with several adverse effects affecting the quality of life of the patients. Also, cisplatin therapy is jeopardized by a great challenge of resistance which reduces the efficacy of this drug. In order to conquer these dark sides of cisplatin therapy, curcumin has been widely used to fight against cisplatin-resistant cancer cells and decrease its unwanted side effects (e.g. ototoxicity, nephrotoxicity and neurotoxicity). In this review, we provide a summary of the studies done to show the protective effects of curcumin against cisplatin failure and toxicity.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Cisplatin; Curcumin; Resistance; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 28042086     DOI: 10.1016/j.phrs.2016.12.037

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  30 in total

Review 1.  Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Kowsar Bavarsad; George E Barreto; Mousa-Al-Reza Hadjzadeh; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-06-09       Impact factor: 5.590

2.  Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats.

Authors:  Ghadha Ibrahim Fouad; Kawkab A Ahmed
Journal:  Cardiovasc Toxicol       Date:  2021-11-27       Impact factor: 3.231

Review 3.  Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.

Authors:  Ivan K Domingo; Asna Latif; Amit P Bhavsar
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

4.  A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases.

Authors:  Masoumeh Atefi; Mina Darand; Mohammad Hassan Entezari; Tannaz Jamialahmadi; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Curcumin: A Review of Its Effects on Epilepsy.

Authors:  Fatemeh Forouzanfar; Muhammed Majeed; Tannaz Jamialahmadi; Amirhosein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury.

Authors:  Filiz Mercantepe; Tolga Mercantepe; Atilla Topcu; Adnan Yılmaz; Levent Tumkaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-02       Impact factor: 3.000

7.  Molecular Mechanisms of Curcumin Renoprotection in Experimental Acute Renal Injury.

Authors:  Youling Fan; Hongtao Chen; Huihua Peng; Fang Huang; Jiying Zhong; Jun Zhou
Journal:  Front Pharmacol       Date:  2017-12-12       Impact factor: 5.810

8.  A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.

Authors:  Weiyong Hong; Fangyuan Guo; Nan Yu; Sanjun Ying; Bang Lou; Jiangqing Wu; Ying Gao; Xugang Ji; Haiying Wang; Aiqin Li; Guoping Wang; Gensheng Yang
Journal:  Drug Des Devel Ther       Date:  2021-06-30       Impact factor: 4.162

Review 9.  Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy.

Authors:  Chunfeng Xu; Mingjie Wang; Wei Guo; Wei Sun; Yuelian Liu
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

10.  Lobaplatin-based regimens outperform cisplatin for metastatic breast cancer after anthracyclines and taxanes treatment.

Authors:  Zhipeng Wang; Lei Xu; Han Wang; Zhenzhi Li; Lu Lu; Xiaojia Li; Qingyuan Zhang
Journal:  Saudi J Biol Sci       Date:  2018-01-31       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.